<SEC-DOCUMENT>0001829126-25-000033.txt : 20250522
<SEC-HEADER>0001829126-25-000033.hdr.sgml : 20250522
<ACCEPTANCE-DATETIME>20250103171113
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001829126-25-000033
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Titan Acquisition Corp.
		CENTRAL INDEX KEY:			0002009183
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		ORGANIZATION NAME:           	05 Real Estate & Construction
		EIN:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		C/O WINSTON & STRAWN LLP
		STREET 2:		800 CAPITOL ST., STE 2400
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77002
		BUSINESS PHONE:		3477204333

	MAIL ADDRESS:	
		STREET 1:		C/O WINSTON & STRAWN LLP
		STREET 2:		800 CAPITOL ST., STE 2400
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77002
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0"></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="corresp_001.jpg" ALT="" STYLE="height: 79px; width: 600px"></FONT></P>



<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0"></P>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0"></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 3, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>VIA
EDGAR</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
States Securities and Exchange Commission<BR>
Division of Corporation Finance<BR>
Office of Real Estate &amp; Construction</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100
F Street, NE<BR>
Washington, DC 20549</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Re:</B></FONT></TD>
    <TD STYLE="text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Titan
                                    Acquisition Corp.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amendment No. 2 to</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Draft Registration Statement
    on Form S-1</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Submitted November 5,
    2024</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CIK No. 0002009183</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
behalf of our client, Titan Acquisition Corp. (the &ldquo;<U>Company</U>&rdquo;), we are writing to submit the Company&rsquo;s responses
to the comments of the staff (the &ldquo;<U>Staff</U>&rdquo;) of the Division of Corporation Finance of the United States Securities
and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) set forth in its letter, dated December 23, 2024, relating to the Company&rsquo;s
Amendment No. 2 to Draft Registration Statement on Form S-1, confidentially submitted to the Commission on November 5, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is concurrently filing via EDGAR Registration Statement on Form S-1 (the &ldquo;<U>Form S-1</U>&rdquo;), which reflects the Company&rsquo;s
responses to the comments received by the Staff and certain updated information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have set forth below the comments in the Staff&rsquo;s letter, in bold, and the Company&rsquo;s responses thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Amendment
No. 2 to Draft Registration Statement on Form S-1 submitted November 26, 2024</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cover
Page</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0%; font-size: 10pt"></TD>
    <TD STYLE="width: 0.25in; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preceding
    the dilution table, please provide a cross-reference, highlighted by prominent type or in another manner, to the locations of related
    disclosures in the prospectus. See Item 1602(a)(4) of Regulation S-K.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Response</U>:
</B>The Company acknowledges the Staff&rsquo;s comment and advises the Staff that it has revised its disclosure on the cover page to
address the Staff&rsquo;s comment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0%; font-size: 10pt"></TD>
    <TD STYLE="width: 0.25in; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please
    revise your cover page to provide all of the disclosure required by Item 1602(a)(3) of Regulation S-K and please describe the extent
    to which compensation and the issuance of securities may result in a material dilution of the purchasers&rsquo; equity interests.
    Further, we note your disclosure in paragraph 11 with respect to how the anti-dilution adjustment may result in material dilution.
    Please also address whether the exercise of the private warrants on a cashless basis and the conversion of the working capital loans
    into units may result in a material dilution of the purchasers&rsquo; equity interests. Please similarly revise your disclosure on
    pages 11 and 106 outside the table to clearly state that the conversion of the warrants on a cashless basis may result in material
    dilution. Additionally, please specifically revise to address the 6,325,000 shares purchased by the founders and the nominal price
    paid for these shares. Please refer to Items 1602(a)(3), 1602(b)(6), and 1603(a)(6) of Regulation S-K.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Response</U>:
</B>The Company acknowledges the Staff&rsquo;s comment and advises the Staff that it has revised its disclosure on the cover page  and pages 15 and 115 to
address the Staff&rsquo;s comment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0%; font-size: 10pt"></TD>
    <TD STYLE="width: 0.25in; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please
    revise your disclosure to clearly state that there may be actual or potential material conflicts of interest between the sponsor,
    its affiliates, or promoters; and purchasers in the offering. Please also provide cross- references to include cross-references to
    all related disclosures in the prospectus and ensure that such cross-references are highlighted by prominent type. See Item 1602(a)(5)
    of Regulation S-K.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Response</U>:
</B>The Company acknowledges the Staff&rsquo;s comment and advises the Staff that it has revised its disclosure on the cover page to
address the Staff&rsquo;s comment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0%"></TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We note that possibly
    15 institutional investors may purchase shares in your public offering. Please disclose whether such purchases could impact your
    ability to list on the NASDAQ Global Market and provide risk factor disclosure as appropriate.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Response</U>:
</B>The Company acknowledges the Staff&rsquo;s comment and advises the Staff that it has revised its disclosure on the cover page to
address the Staff&rsquo;s comment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Summary,
page 1</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0px"></TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please revise the appropriate
    section of your Summary to disclose that your ability to identify and evaluate a target company may be impacted by significant competition
    among other SPACs in pursuing a business combination transaction candidate and that significant competition may impact the attractiveness
    of the acquisition terms that you will be able to negotiate. In this regard, we note your disclosure on page 47 that there are numerous
    other entities seeking targets with which you will compete.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Response</U>:
</B>The Company acknowledges the Staff&rsquo;s comment and advises the Staff that it has revised its disclosure on page 11 to address
the Staff&rsquo;s comment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Initial
Business Combination, page 8</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0px"></TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We note your disclosure
    on page 32 that you may pay a finder&rsquo;s fee, advisory fee, consulting fee or success fee. Please revise your tables on pages
    10 and 105 to reflect these fees. Please also ensure that your cover page reflects these fees. Please refer to Items 1602(a)(3),
    1602(b)(6), and 1603(a)(6) of Regulation S-K. Further, we note that you intend to pay fees to an advisor. Please identify the advisor
    and, in an appropriate section, please disclose the services to be provided by the advisor.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Response</U>:
</B>The Company acknowledges the Staff&rsquo;s comment and advises the Staff that it has revised its disclosure on pages 14 and 115
to address the Staff&rsquo;s comment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>The
Offering</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Ability
to extend time to complete initial business combination, page 25</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0px"></TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We note your disclosure
    that shareholders may vote to extend the time that you have to complete an initial business combination. Please also disclose whether
    there are any limitations on extensions, including the number of times you may seek to extend. Also disclose the consequences to
    the sponsor of not completing an extension of this time period. See Item 1602(b)(4) of Regulation S-K.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Response</U>:
</B>The Company acknowledges the Staff&rsquo;s comment and advises the Staff that it has revised its disclosure on page 30 to address
the Staff&rsquo;s comment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Permitted
purchases of public shares and public warrants by our affiliates, page 26</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0px"></TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We note that you may
    purchase shares to effect the initial business combination and we note that, pursuant to the letter agreement, your sponsor, officers
    and directors have agreed to vote their shares in favor of the initial business combination. Please revise your disclosure to clarify
    how you will comply with Rule 14e-5. Please also refer to Tender Offer Rules and Schedules Compliance and Disclosure Interpretation
    166.01 for guidance.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Response</U>: </B>The
Company acknowledges the Staff&rsquo;s comment and advises the Staff that it has revised its disclosure on page 23 and 33 to
address the Staff&rsquo;s comment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Use
of Proceeds, page 84</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
                                            note your statement in footnote 5 that you have assumed the cost for the office and administrative
                                            support for only 12 months. Please explain the calculation for the amount, because we note
                                            your disclosure indicates that you will reimburse your sponsor $10,000 per month for use
                                            of office space and for administrative support.</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Response</U>:
</B>The Company acknowledges the Staff&rsquo;s comment and advises the Staff that it has revised its disclosure on page 91 to address
the Staff&rsquo;s comment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Dilution,
page 88</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
                                            refer you to your dilution table here, on the cover page, and on pages 33-34. Please address
                                            the following:</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
                                            note your dilution is presented in quartile intervals based on 100% of the offering, rather
                                            than based on percentages of your maximum redemption threshold. Refer to Item 1602(a)(4)
                                            of Regulation S-K. Please revise here and elsewhere.</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please
                                            ensure your column headers are correctly labeled.</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>It
                                            appears the amounts paid for redemptions in the maximum redemptions columns are assuming
                                            a $10.05 redemption value per share but your other intervals are assuming a $10.00 redemption
                                            value per share. Please reconcile or revise.</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>It
                                            appears that the amounts used in your maximum redemptions columns are intended to arrive
                                            at a $5,000,001 positive net book value. However, it appears that the amounts used resulted
                                            in a negative net book value of $5,000,001. Please revise or advise.</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
                                            above bullet point not withstanding, it appears the amounts presented as the amounts paid
                                            for redemptions in the maximum redemptions columns on page 89 (i.e., $220,000,000 and $253,000,000)
                                            are inconsistent with the amounts used on page 34 (i.e., $217,257,401 and $248,501,801).
                                            Please revise for consistency.</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please
                                            revise to remove the last paragraph on page 89, or tell us how such disclosure is applicable
                                            to your dilution disclosures.</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Response</U>:
</B>The Company acknowledges the Staff&rsquo;s comment and advises the Staff that it has revised its disclosure on page 95 to address
the Staff&rsquo;s comment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please
                                            expand your disclosure on page 88 to narratively describe each material potential source
                                            of future dilution not included in the table. Your revisions should address, but not be limited
                                            to, anti-dilution provisions in the Class B ordinary shares and ordinary shares to be issued
                                            to shareholders of a potential business combination target as consideration. Please also
                                            expand your narrative disclosure on page 33 to address the anti-dilution provisions in the
                                            Class B ordinary shares. Reference is made to Item 1602(c) of Regulation S-K.</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Response</U>:
</B>The Company acknowledges the Staff&rsquo;s comment and advises the Staff that it has revised its disclosure on page 95 to address
the Staff&rsquo;s comment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Proposed
Business, page 98</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0px"></TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please revise to specifically
    identify all of the persons who have a direct or indirect material interest in the SPAC sponsor, as well as the nature and amount
    of their interests, as required by Item 1603(a)(7) of Regulation S-K. Please also revise your disclosure on page 128 to discuss the
    membership interests in the sponsor that your independent directors will receive for their services as a director. See Item 402(r)(3)
    of Regulation S-K.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Response</U>:
</B>The Company acknowledges the Staff&rsquo;s comment and advises the Staff that it has revised its disclosure on page 103 to address
the Staff&rsquo;s comment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Sourcing
of Potential Initial Business Combination Targets, page 103</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0px"></TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We note your disclosure
    regarding the agreement with your sponsor, directors and officers not to transfer your shares prior to the business combination.
    Please disclose if there are any circumstances or arrangements under which your sponsor, its affiliates, and promoters, directly
    or indirectly, have transferred or could transfer ownership of securities of the SPAC, or that have resulted or could result in the
    surrender or cancellation of such securities. To the extent your sponsor could remove itself as your sponsor through the transfer
    of securities prior to the initial business combination, please add risk factor disclosure to address the risks associated with such
    removal. If there are no circumstances under which this could occur, please so state. Please refer to Item 1603(a)(6) of Regulation
    S-K.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Response</U>:
</B>The Company acknowledges the Staff&rsquo;s comment and advises the Staff that it has revised its disclosure on page 113 to address
the Staff&rsquo;s comment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Previous
SPAC Experience, page 126</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0px"></TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For each prior SPAC,
    please disclose whether an entity was able to complete the business combination within the original completion window or whether
    there have been any extensions of time to complete the transaction or if they have not yet completed a combination, whether there
    have been extensions. Please include disclosure regarding the number of times each has sought to extend and amount of time you have
    extended the completion window by to complete a transaction. See Item 1603(a)(3) of Regulation S-K.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Response</U>:
</B>The Company acknowledges the Staff&rsquo;s comment and advises the Staff that it has revised its disclosure on page 135 to address
the Staff&rsquo;s comment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Notes
to Financial Statements </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Note
4. Private Placement, page F-11</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0px"></TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We note your response
    to prior comment 3 and your revisions to your Note 7. We refer you to your continued disclosure in Note 4 on pages F-11, F-26, and
    F-41, which states &ldquo;The Private Placement Warrants will be non-redeemable for cash and exercisable on a cashless basis so long
    as they are held by the Sponsor or its permitted transferees.&rdquo; Please revise to remove this disclosure from Note 4, or advise.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Response</U>:
</B>The Company acknowledges the Staff&rsquo;s comment and advises the Staff that it has revised its disclosure on pages F-11, F-26, and F-41 to address
the Staff&rsquo;s comment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
* * * * * *</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you have any questions, please feel free to contact me at (713) 651-2678. Thank you for your cooperation and prompt attention to this
matter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Michael J. Blankenship</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael J. Blankenship</FONT></TD></TR>
  </TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>

    <!-- Field: /Page -->



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>corresp_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 corresp_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !] [8# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8'0<UXY^T)_R -)ZX^U@=>M>P0R),B2(<HRAD;U!%>/_ +0G_("TGKG[4.]
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MGZ^O6GTP\/U[<T_F@ [4444 %%)D4O?% !11T%)G S0 M%%% !1110 4444
M%%%% !1110 4449YH ***3/&: %HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#!\7:!!XH\,WVE7+A%E0[7
M/&T]C7BOA?XH:AX=T:Y\'BV:_P!9MY#;V3QG*N.Q_"NE\;:WJWC#QK_P@N@W
M#VMO'SJ%Q'P0.XR*?XG^#UG9>';>Y\, P:SIO[U9B<M,1UR: -WX9>";OPW!
M=ZMK$GG:SJ+&2<XR4SVKT 'CCKZ8KR*V^+4D_P -;W4?DCU_3QY4T$G=P<9K
MT/PAJ-WJ_A33]0OHPMS<1!W 'K0!P/QUT._OM#L=5T^-I)-/E$A5>3CUK5\%
M_%?P[KVF6T%S>1V=^B*CQ2G'(QTKT)PC@QN ZL,%2,Y^M<!XB^#OA/7B\J6G
MV.Y?)\R XY]Z .]BF2:(/'(LB_WD;(/^%2#KV] *^?=$NM=^%7Q!M?#U_>M>
M:1?-MC+G.!V-?0"X)# Y!&1[^] 'B7Q2_P"2N^%/][^M>WKC8OT%>(?%/_DK
MOA/']ZO;U (7O@4 >'>-!GX_: N/X!_^NO8]6U:RT:PFOKVYCBBB4DEV _"O
M"_BG97FH_&'3+73KC[/>M#F&3T;M5#P;H?\ PF?B6]T;QKK=XU_:R?+:,^%D
MP>OI0!T_P3MYM0\0^(O$?E,EK=S'R6(QD9/^/\Z]ISR,=^.O-5=,TRRT?3X[
M'3[=8+:$85$&*Q/'WB:/PIX2O-29OWQ7RX5]7/ H \^\0/)\1/BO::)"2^E:
M.1-<D'Y68'I_GTJ?XNZ7/H.I:1XVTI</8.L=PJ#JG_ZJPO"'PK\3W6EC6T\1
M2:;>:C^]E0 Y(///YUM7GPB\47]C+:7GC"6>"12&B8'YJ .ZU2UL_'GP]E2,
MJ\5];;D/HV,URGP0UN6?0+KP]>G%WI4IBP>I4'BJ?P:U:XTF[U'P1JA(NK!R
M82?XDSVJEK:GP#\;+35$&S3M9Q'+C@!J .@^-6@'4?"BZO;D+>Z7()HW[\5D
M_ ^QN-52_P#&&I.);N[;RE?N .*O?&'4Y[\Z7X/T]S]HU64"7:?NQ\<UC_"]
MI_!/CO4? ]]*6B<>9:LW\7&30!UOQ@\1-H/@>>*!S]LO2((@#SSQQ6E\-/#B
M^%_!-C9E0)Y5\Z8]RQ&3FN$U\-X\^--CI*$MI^C#S9@>F_T_.O:550!M& .
M/04 ?/\ H>B:?XD^,7BG3=2@$L,L9 )Y*GM5OP]JVI?"+Q,/#FNM)-H-R_\
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MF0H6';/>N9U#X?:=J/A:ST*X<LMI()8Y>X(.: ,OS]5US4)+*QO6LH=-ME.
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M6F?!<EQI4MAJ&IRW*9!A;O'CIQWZ5;TSPN]MKBZM=W[W-RL7DCT % '355U
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
:HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
